Transcend Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,222	Closed	-$211K	–	496
2021 Q3	$211K	Buy	+2,222	New	+$211K	0.02%	448
2021 Q2	–	Sell	-1,922	Closed	-$234K	–	340
2021 Q1	$234K	Buy	+1,922	New	+$234K	0.03%	357